Therapeutic inhibition of DNA-Damage Response and PI3K/AKT signaling in Acute Myleoid Leukemia: A novel therapeutic strategy to boost chemotherapy response and overcome resistance

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt